122 related articles for article (PubMed ID: 6864524)
1. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.
Billings RE
J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524
[TBL] [Abstract][Full Text] [Related]
2. Oxygen-18 incorporation studies of the metabolism of phenytoin to the catechol.
Billings RE; Fischer LJ
Drug Metab Dispos; 1985; 13(3):312-7. PubMed ID: 2861989
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin metabolism in mice.
Chow SA; Fischer LJ
Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
Moustafa MA; Claesen M; Adline J; Vandervorst D; Poupaert JH
Drug Metab Dispos; 1983; 11(6):574-80. PubMed ID: 6140142
[TBL] [Abstract][Full Text] [Related]
6. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
Butler TC; Dudley KH; Mitchell GN; Johnson D
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
Huang JD; Hsieh CY
Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
[TBL] [Abstract][Full Text] [Related]
8. Influence of pregnancy and folic acid on phenytoin metabolism by rat liver microsomes.
Blake DA; Collins JM; Miyasaki BC; Cohen F
Drug Metab Dispos; 1978; 6(3):246-50. PubMed ID: 26544
[TBL] [Abstract][Full Text] [Related]
9. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.
Roy D; Snodgrass WR
Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010
[TBL] [Abstract][Full Text] [Related]
10. Search for 5-(2-hydroxyphenyl)-5-phenylhydantoin as a metabolite of phenytoin.
Poupaert JH; Moustafa M; Smeyers C; Adline J; Vandervorst D; Claesen M; Dumont P
J Pharm Belg; 1982; 37(1):47-52. PubMed ID: 7077512
[No Abstract] [Full Text] [Related]
11. Bromobenzene metabolism in vivo and in vitro. The mechanism of 4-bromocatechol formation.
Miller NE; Thomas D; Billings RE
Drug Metab Dispos; 1990; 18(3):304-8. PubMed ID: 1974190
[TBL] [Abstract][Full Text] [Related]
12. Stereochemical aspects of the metabolism of 5-(4'-fluorophenyl)-5-phenylhydantoin in the rat.
Poupaert JH; Adline J; Claesen MH; De Laey P; Dumont PA
J Med Chem; 1979 Sep; 22(9):1140-2. PubMed ID: 490562
[TBL] [Abstract][Full Text] [Related]
13. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
[TBL] [Abstract][Full Text] [Related]
14. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
O'Leary TD; Sansom LN
J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
[TBL] [Abstract][Full Text] [Related]
15. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
Kapetanovic IM; Kupferberg HJ
Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
[TBL] [Abstract][Full Text] [Related]
16. A comparison of diphenylhydantoin metabolism in different tissues using high performance liquid chromatography.
MacKinney AA; Shinnick FL; Gorder C
Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):395-411. PubMed ID: 7122986
[TBL] [Abstract][Full Text] [Related]
17. Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice.
Atlas SA; Zweier JL; Nebert DW
Dev Pharmacol Ther; 1980; 1(5):281-304. PubMed ID: 7438974
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice.
Hansen DK; Hodes ME
Drug Metab Dispos; 1983; 11(1):21-4. PubMed ID: 6132790
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 2-chloroethyl nitrosocarbamoylcystamine by rat liver subcellular fractions.
Godeneche D; Madelmont JC; Moreau MF; Duprat J; Plagne R; Meyniel G
Drug Metab Dispos; 1986; 14(1):112-7. PubMed ID: 2868853
[TBL] [Abstract][Full Text] [Related]
20. The effect of pregnancy on the metabolism of [14C]phenytoin in the isolated perfused rat liver.
Vore M; Bauer J; Pascucci V
J Pharmacol Exp Ther; 1978 Aug; 206(2):439-47. PubMed ID: 682124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]